The PAI-1 4G/5G mutation did not increase the risk for the development of thrombosis, pregnancy morbidity or thrombocytopenia in our APS patients, which may be due to the genetic variation between races. The gene discussed is SERPINE1; the disease is autoimmune polyendocrinopathy.